<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00591513</url>
  </required_header>
  <id_info>
    <org_study_id>FD-R-672</org_study_id>
    <secondary_id>FD-R-672</secondary_id>
    <secondary_id>NIH-RO1-GM50509</secondary_id>
    <nct_id>NCT00591513</nct_id>
    <nct_alias>NCT00004413</nct_alias>
  </id_info>
  <brief_title>Autologous Engineered Skin Substitutes for Closure of Skin Wounds</brief_title>
  <official_title>Autologous Engineered Skin Substitutes for Closure of Burn Wounds</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cincinnati</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Cincinnati</source>
  <brief_summary>
    <textblock>
      This clinical trial tests the hypothesis that engineered human skin can reduce the
      requirements for harvesting of conventional skin autografts by providing more skin for
      grafting from the donor skin used to treat the wounds. In life-threatening burns (e.g.,
      greater than 50% of the total body surface area), greater availability of skin may be
      definitive to patient survival, and may reduce scar formation at the donor site, and from use
      of widely-meshed skin autograft.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>February 1998</start_date>
  <completion_date type="Actual">January 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The ratio of closed wound area to donor skin area for engineered skin substitutes compared to meshed, split-thickness skin autograft.</measure>
    <time_frame>Post-operative day 28+/-3</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Qualitative outcome of scar formation of engineered skin substitutes or meshed, split-thickness skin autograft by the Vancouver Scar Scale which evaluates erythema (redness), pigmentation (color), pliability (softness), and scar height (smoothness).</measure>
    <time_frame>Post operative days 28+/-3 and 365+/-30</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">144</enrollment>
  <condition>Burns</condition>
  <condition>Burn Scars</condition>
  <condition>Congenital Giant Nevi</condition>
  <arm_group>
    <arm_group_label>Acute burn wounds</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Comparative grafting of acute burn wounds with autologous engineered skin and meshed, split-thickness autograft skin.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Reconstruction of burn scars.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Congenital, giant melanocytic nevus.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Autologous engineered skin substitutes</intervention_name>
    <description>Autologous skin cells combined with a biopolymer sponge which is transplanted to excised, full-thickness burns, excised or incised burn scars, or excised full-thickness congenital giant melanocytic nevus. Repeated administrations until all skin wounds are closed.</description>
    <arm_group_label>Acute burn wounds</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
    <other_name>Autologous Cultured Skin Substitutes</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Burns greater than 50% of the total body surface area (TBSA), including 10% TBSA
             full-thickness injury

          -  Subject is not septic

          -  Skin grafting expected after 3 weeks following the skin biopsy

          -  Informed Consent signed.

        Exclusion Criteria:

          -  Subject is pregnant or lactating

          -  Subject is a prisoner

          -  Subject is mentally incompetent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Kagan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 27, 2007</study_first_submitted>
  <study_first_submitted_qc>January 10, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 11, 2008</study_first_posted>
  <last_update_submitted>July 14, 2015</last_update_submitted>
  <last_update_submitted_qc>July 14, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 15, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>burns</keyword>
  <keyword>burn scars</keyword>
  <keyword>congenital giant nevi</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Burns</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

